Jeffrey Hung
Stock Analyst at Morgan Stanley
(0)
# 4250
Out of 5,240 analysts
239
Total ratings
43.30%
Success rate
-8.72%
Average return
Main Sectors:
Top Industries:
Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
PTC Therapeutics | Upgrades: Overweight | 45 67 | 43.22 | 55.02% | 10 | Dec 13, 2024 | |
Amicus Therapeutics | Downgrades: Equal-Weight | 17 12 | 9.26 | 29.59% | 4 | Dec 13, 2024 | |
Bioage Labs | Initiates Coverage On: Overweight | 40 | n/a | n/a | 1 | Oct 21, 2024 | |
Intra-Cellular Thera... | Maintains: Overweight | 92 95 | 126.73 | -25.04% | 5 | Oct 11, 2024 | |
Centessa Pharmaceuti... | Upgrades: Overweight | 11 26 | 15.4 | 68.83% | 1 | Sep 19, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 40 40 | 7.58 | 427.7% | 2 | Sep 11, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 28 20 | 17.11 | 16.89% | 23 | Aug 7, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 35 | 2.12 | 1550.94% | 1 | Jul 26, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 160 150 | 122.63 | 22.32% | 4 | Jul 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 160 170 | 140.08 | 21.36% | 22 | Jul 12, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 50 70 | 37.06 | 88.88% | 2 | May 23, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 25 | 13.56 | 84.37% | 1 | Apr 30, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 75 40 | 59.34 | -32.59% | 5 | Apr 2, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Overweight | 55 | 29.21 | 88.29% | 1 | Feb 20, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 60 90 | 47.28 | 90.36% | 12 | Jan 5, 2024 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 295 330 | n/a | n/a | 3 | Dec 22, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 10 4 | 1.04 | 284.62% | 10 | Dec 19, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 13 4 | 1.83 | 118.58% | 1 | Dec 19, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 29 55 | 54.37 | 1.16% | 10 | Dec 19, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 1 4 | 0.39 | 925.64% | 1 | Dec 19, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Equal-Weight | 60 140 | 8.34 | 1578.66% | 1 | Dec 8, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 90 84 | 42.46 | 97.83% | 7 | Nov 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 42 40 | 14.59 | 174.16% | 4 | Nov 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 14 14 | 1.94 | 621.65% | 3 | Aug 4, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Reiterates: Equal-Weight | 5 5 | 1.72 | 190.7% | 1 | Jul 11, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 9 3 | 2.21 | 35.75% | 8 | Mar 20, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 15 14 | 1.3 | 976.92% | 7 | Feb 27, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 42 21 | n/a | n/a | 4 | Feb 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 27 19 | 10.01 | 89.81% | 5 | Feb 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Upgrades: Overweight | 15 | 1.97 | 661.42% | 2 | Feb 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 4 2 | n/a | n/a | 3 | Feb 3, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 50 10 | 2.18 | 358.72% | 3 | Jan 30, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 22 30 | n/a | n/a | 6 | Jan 10, 2023 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 23 22 | 36.33 | -39.44% | 10 | Nov 2, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 2 2 | n/a | n/a | 5 | Sep 9, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Underweight | 250 94 | n/a | n/a | 8 | Jul 15, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 146 149 | 36.74 | 304.19% | 2 | May 11, 2022 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 180 | n/a | n/a | 12 | Oct 1, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Underweight | 100 60 | 3.83 | 1466.58% | 5 | Aug 13, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Equal-Weight | 7 6 | 5.23 | 14.72% | 9 | Apr 19, 2021 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Equal-Weight | 121 225 | n/a | n/a | 9 | Oct 6, 2020 | |
XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Overweight | 58 54 | 0.78 | 6823.08% | 6 | May 8, 2020 |